| Filed On | Filing |
|---|---|
| 29 Sep 2026 |
8-K: Entry into a Material Definitive Agreement
THIS AMENDMENT TO PROMISSORY NOTE (this “Amendment”) is made and entered into as of September 25, 2026, by and between Vivasor, Inc., a Delaware corporation (the “Company”), and Scilex Holding Company, a Delaware corporation (the “Holder”). |
| 12 Aug 2026 |
8-K: Entry into a Material Definitive Agreement
FOR VALUE RECEIVED, Vivasor, Inc. (the “Company”) located at 9380 Judicial Dr, San Diego, CA 92121, hereby promises to pay Scilex Holding Company (the “Holder”), a Delaware corporation, having a principal place of business at 960 San Ant... |
| 22 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets
This Stock Repurchase Agreement (this “Agreement”) is made and entered into effective as of July 18, 2026 (the “Effective Date”) by and among (i) Vivasor Holding Company, a Delaware corporation (the “Company”), (ii) Vivasor, Inc., a Dela... |
| 06 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP |
| 29 Jun 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
On June 24, 2026, Scilex Holding Company (the “Company”) entered into a binding term sheet (the “Term Sheet”) with Datavault AI Inc. (“Datavault”), which sets forth certain terms and conditions of the Company’s proposed purchase (the “Pr... |
| 24 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On June 24, 2026, Scilex Holding Company (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Meeting”). At the Meeting, a total of (i) 29,057,097 shares of the Company’s Series A preferred stock, $0.0001 par value per shar... |
| 11 May 2026 |
8-K: Other Events
This FAQ addresses details of the distribution of the Dream Bowl Meme Coin I tokens to certain record holders of common stock and certain other equity securities of Scilex Holding Company (the “Company”), including the record date, payme... |
| 05 May 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited |
| 28 Apr 2026 |
8-K: Entry into a Material Definitive Agreement
On April 26, 2026, Scilex Holding Company (the “Company”) and Datavault AI Inc. (“Datavault”) and entered into a binding term sheet (the “Term Sheet”), which sets forth the principal terms and conditions of a proposed cash contribution a... |
| 13 Mar 2026 |
8-K: Regulation FD Disclosure
Scilex Holding Company Files Federal Securities Fraud Lawsuit Seeking Recovery of Approximately Ninety-Six (96) Million Misappropriated Collateral Shares of Datavault AI, Inc. from Marc Wade, The St. James Bank & Trust Company Ltd., Omeg... |
| 13 Mar 2026 |
8-K: Regulation FD Disclosure
Marc E. Kasowitz (pro hac vice application forthcoming) [email protected] |
| 20 Feb 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURIT... |
| 03 Feb 2026 |
8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year
In accordance with Section 151(g) of the General Corporation Law of the State of Delaware (the “DGCL”), Scilex Holding Company, a corporation organized and existing under the General Corporation Law of the State of Delaware (hereinafter ... |
| 02 Feb 2026 |
8-K: Entry into a Material Definitive Agreement
Scilex Holding Company (the “Company”) entered into a Convertible Promissory Note, dated January 29, 2026 (the “Note”), with Quantum Scan Holdings, Inc. (“Q Scan”). Pursuant to the Note, the Company loaned Q Scan an aggregate of $20 mill... |
| 30 Dec 2025 |
8-K: Regulation FD Disclosure
As previously disclosed, Scilex Holding Company (the “Company”) issued to Oramed Pharmaceuticals Inc., a Delaware corporation (“Oramed”), on September 21, 2023, warrants to purchase up to an aggregate of 6,500,000 shares of common stock,... |
| 22 Dec 2025 |
8-K: Regulation FD Disclosure
As previously disclosed, on December 1, 2025, Scilex Holding Company (the “Company”) entered into a Non-Recourse Loan and Securities Pledge Agreement (the “Loan Agreement”) with The St. James Bank & Trust Company Ltd., a corporation exis... |
| 17 Dec 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
THIS AGREEMENT dated with effect as of the 15th day of December, 2025 |
| 12 Dec 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
This Amendment to Non-Recourse Loan and Securities Pledge Agreement (this “Amendment”) is made and effective as of December 8, 2025 between The St. James Bank and Trust Company Ltd. and Scilex Holding Company. |
| 11 Dec 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
On December 11, 2025 (the “Repricing Date”), Scilex Holding Company (the “Company”) held a special meeting of stockholders (the “Special Meeting”) in a virtual meeting format via live webcast. As further described in Item 5.07 to this Cu... |
| 05 Dec 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
THIS AGREEMENT dated with effect as of the 1st day of December, 2025 |
Loading...